Blood Biomarker Linked to Incident VTE in COVID-19 Patients

MONDAY, Aug. 22, 2022 -- Higher levels of soluble urokinase plasminogen activator receptor (suPAR) are associated with incident venous thromboembolism (VTE) among patients hospitalized for COVID-19, regardless of D-dimer levels, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news